Verapamil improves the pacing-induced vasodilatation in symptomatic patients with hypertrophic cardiomyopathy

International Journal of Cardiology

Volumn 83, Issue 3, 2002, Pages 239-247

  Dimitrow, Pawel Petkow ^a   Krzanowski, Marek ^a   Grodecki, Janusz ^a   Malecka, Barbara ^a   Lelakowski, Jacek ^a   Kawecka Jaszcz, Kalina ^a   Szczeklik, Andrzej ^a   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Endothelium dependent vasodilatation; Hypertrophic cardiomyopathy; Verapamil

Indexed keywords

VERAPAMIL;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DRUG EFFECT; DRUG WITHDRAWAL; ENDOTHELIUM; FEMALE; HEART PACING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MEASUREMENT; PRIORITY JOURNAL; STRESS; VASODILATATION;

ADULT; BLOOD FLOW VELOCITY; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY CIRCULATION; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; SYSTOLE; VASODILATION; VASODILATOR AGENTS; VERAPAMIL;

EID: 0036258732     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00071-2     Document Type: Article

References (52)

1. Intramural ('small vessel') coronary disease in hypertrophic cardiomyopathy
2. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy
3. Alterations of architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: A possible cause for myocardial ischemia
4. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation
5. Ultrastructural changes of blood capillaries in patients with microvascular angina, hypertrophic cardiomyopathy, and dilated cardiomyopathy
6. Luminal narrowing of coronary capillaries in human hypertrophic hearts: An ultrastructural morphometrical study using endomyocardial biopsy specimens
7. Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment
8. Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy
9. Coronary flow reserve is supranormal in endurance athletes: An adenosine transthoracic echocardiographic study
10. Coronary flow reserve improves after aortic valve replacement for aortic stenosis: An adenosine transthoracic echocardiography study
11. Verapamil improves of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy
12. Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy
13. Assessment of endothelium dependent coronary vasodilatation in hypertrophic cardiomyopathy [abstract]
14. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand
15. Contribution of nitric oxide to metabolic coronary vasodilatation in the human heart
16. Myocardial ischemia in patients with hypertrophic cardiomyopathy: Contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures
17. Differences in coronary flow and myocardial metabolism at rest and during pacing between patients with obstructive and patients with nonobstructive hypertrophic cardiomyopathy
18. Mechanism responsible for angina pectoris in hypertrophic cardiomyopathy
19. Changes in phasic coronary flow velocity profile and relative coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy
20. Mechanical adaptation of heart rate change for coronary circulation in patients with and without ventricular hypertrophy
21. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension
22. Task force on the definition and classification of cardiomyopathies
23. Hypertrophic cardiomyopathy: A discussion of nomenclature
24. Transthoracic Doppler echocardiographic analysis of phasic coronary flow velocity in hypertrophic cardiomyopathy
25. Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography. Comparison with invasive technique
26. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve
27. Effects of various doses of intracoronary verapamil on coronary resistance vessels in humans
28. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy
29. Coronary vasoconstriction during myocardial ischemia by rises in metabolic demand in patients with coronary artery disease
30. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic cardiomyopathy
31. Coronary vasodilator reserve in primary and secondary left ventricular hypertophy: A study with positron emission tomography
32. Does pharmacologic coronary flow reserve reflect vasodilator responsiveness to increased myocardial demand in humans?
33. Paradoxical narrowing of atherosclerotic coronary arteries induced by increases in heart rate
34. Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure and ventricular preload
35. Effect of verapamil on systolic and diastolic coronary flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy
36. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency, effect of verapamil and trandolapril
37. Calcium-channel blockers preserve endothelial reactivity after ischemia-reperfusion
38. 1-adrenoceptors
39. Interactions between calcium channel blockers and alpha-adrenoceptors in the human coronary and mammary arteries: A radioligand binding study
40. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines
41. Augmented α-adrenergic constriction of atherosclerotic human coronary arteries
42. Interdependence of pharmacologically-induced and endothelium-mediated coronary vasodilatation in antianginal therapy
43. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: Studies in perfused mesenteric resistance arteries
44. Different potencies of endothelium-derived relaxing factors against thromboxane and endothelin-1 in coronary arteries: Comparison with nitrovasodilator and calcium antagonists
45. Effect of diltiazem and verapamil on endothelin release by cultured human coronary smooth-muscle cells and endothelial cells
46. Mircocirculation: What is the role of calcium antagonists?
47. Transluminal subselective measurement of coronary artery flow velocity and vasodilator reserve in man
48. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's ischemia syndrome evaluation (WISE) study
49. Comparison between positron emission tomography myocardial perfusion imaging and intracoronary Doppler flow velocity measurements at and during cold pressor testing in angiographically normal coronary arteries in patients with one-vessel coronary artery disease
50. Evaluation of the extent and timing of the coronary hyperemic response to dipyridamole: A study with transesophageal echocardiography and positron emission tomography with oxygen 15 water
51. Coronary flow reserve: Measurement with transthoracic doppler echocardiography is reproducible and comparable with positron emission tomography
52. Coronary blood flow velocity during apical versus septal pacing